COVID-19 made clear that diagnostic testing is a highly effective tool to curb viral spread. A positive test result informs infectious individuals that they & their close contacts must self-isolate, reducing transmission. #covid19#testing 2/16
As well-endowed institutions––e.g. schools, workplaces––sought to revive operations, they turned inwards, deploying vast resources to test their own members regularly, often w/clinical-grade tests, while surrounding communities suffered testing shortages & delays. 3/16
For example, the NFL spent $100m on daily testing w/24 hour return time, burning through ~1M mostly negative tests. In spite of this, they had outbreaks across a number of teams. They were not alone. 4/16
The White House outbreak & many others show failure of confined testing programs. By not testing the surrounding community, institutions miss a chance for social good & remain blind to community cases that could breach the institution & spread like 🔥🔥 5/16
We hypothesized that institutions that only test themselves would be less safe than those that supported community testing. 6/16
We constructed an #epidemiological model to test this hypothesis, taking an agent-based approach & generating contact network for how agents interact. Beyond typical SEIR compartments, we have quarantine ones that agents enter when they or close contacts test positive. 7/16
We found that the deployment of diagnostic tests to members’ close contacts outside the institution offered the best protection (overall lowest transmission) in practically all tested scenarios. #protection 8/16
Under baseline parameters––modeled on our affiliated institution, @ColoradoMesaU––using about 45% of tests outside the institution was the best way to stay safe. This proportion depends on variable model parameters including interaction and contact tracing levels. 9/16
Going beyond @ColoradoMesaU, our results were robust to a wide range of factors, such as local community prevalence, social mitigation efforts, testing capacity, and contact tracing adoption 10/16
For best performance, institutions would ask members to report close contacts & know who is critical to test. But even w/o perfect reporting, our results show overall transmission w/in institution & beyond is lower when testing is deployed inside & outside the institution. 11/16
Mathematically, our results are hardly surprising. It’s intuitive that if institutions allocate most diagnostic tests to members’ contacts, they will likely preempt the virus’s emergence within their walls by establishing a ‘barrier of defense.’ 12/16
By leveraging a larger % of tests and resources towards strategic testing in surrounding communities, institutions can create circles of safety around them, & limit viral transmission both within and outside their institutional walls. 13/16
Our research justifies #altruistic––and more effective––testing strategies. Early in the pandemic, many institutions chose to devote considerable resources to testing themselves -and themselves only. This policy is neither the most ethical nor the most safe. 14/16
Epidemics are one of those rare instances where a seemingly selfless approach is, in fact, the most self-serving: institutions must test beyond their walls to stay safe behind them. 15/16
A year into the COVID-19 pandemic, we still lack a testing and surveillance system to stop SARS-CoV-2 or respond to new variants that might emerge. How did we get here and where can we go? A thread based on our @NEJMperspective nejm.org/doi/full/10.10… 1/11
U.S. has 3 core issues: 1. limited bandwidth & support for labs to rapidly stand up new tests 2. over-reliance on commercial manufacturers leading to testing shortages & perverse incentives 3. failure to prioritize symptomatic over asymptomatic testing. Some startling facts: 2/11
Of 260,000 CLIA labs, only 45 built their own FDA-approved COVID Laboratory Developed Tests, and only ~200 are using LDTs pre-FDA approval. Even removing all regulations didn’t convince labs to build LDTs, & may have been a deterrent - as loss of oversight adds liability. 3/11